Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-03-05 @ 12:53 PM
Study NCT ID:
NCT01488318
Status:
TERMINATED
Last Update Posted:
2018-01-05
First Post:
2011-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Sponsor:
Organization: